Dynacure
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.
Dynacure has raised €50M across 1 funding round from 1 investor, most recently a Series C round in Feb 2020. Based in Illkirch, France; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€50M
€50,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-02
latest 2020-02
Funding by year
EUR raised per yearDynacure — funding by year — interactive chart.
Data table
| Dynacure — funding by year | |
|---|---|
| 2020 | €50M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-04 | Series C | €50M | Perceptive Advisors | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData